SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-050370
Filing Date
2021-10-07
Accepted
2021-10-07 07:38:22
Documents
15
Period of Report
2021-10-04
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 SCALMIBIO ACQUISITION alxo-8k_20211004.htm   iXBRL 8-K 47889
2 EX-99.1 alxo-ex991_6.htm EX-99.1 16752
3 GRAPHIC gdtrbbldujbq000001.jpg GRAPHIC 27266
  Complete submission text file 0001564590-21-050370.txt   272192

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA alxo-20211004.xsd EX-101.SCH 5945
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alxo-20211004_def.xml EX-101.DEF 13791
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxo-20211004_lab.xml EX-101.LAB 23769
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxo-20211004_pre.xml EX-101.PRE 14580
8 EXTRACTED XBRL INSTANCE DOCUMENT alxo-8k_20211004_htm.xml XML 4959
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 211311063
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences